SCM
IRON icon

Silverarc Capital Management’s Disc Medicine IRON Stock Holding History

Silverarc Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.06M Sell
82,800
-113,228
-58% -$7.78M 0.63% 48
2026
Q1 		$12.5M Buy
+196,028
New +$13.6M 1.28% 22
2025
Q2 		– Sell
-236,471
Closed -$11.7M – 74
2025
Q1 		$11.7M Buy
236,471
+126,090
+114% +$7.01M 2.4% 14
2024
Q4 		$7M Buy
110,381
+6,519
+6% +$377K 1.53% 23
2024
Q3 		$5.1M Buy
103,862
+2,675
+3% +$126K 1.15% 32
2024
Q2 		$4.56M Buy
+101,187
New +$3.44M 1.08% 31

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Silverarc Capital Management's IRON Position: Q2 2026 in Review

Silverarc Capital Management reduced its Disc Medicine (IRON) stake by 58% in Q2 2026, selling an estimated $7.78M and leaving 82,800 shares worth $6.06M. The position accounts for 0.63% of the portfolio, ranked #48.

Silverarc Capital Management first reported a position in IRON in Q2 2024 and has held it in 6 quarters since. The position peaked at $12.5M in Q1 2026. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Silverarc Capital Management held 82,800 shares of Disc Medicine worth $6.06M as of Q2 2026.
  • Silverarc Capital Management sold 113,228 Disc Medicine shares in Q2 2026, an estimated $7.78M.
  • Disc Medicine made up 0.63% of Silverarc Capital Management's portfolio in Q2 2026, its #48 holding.
  • Silverarc Capital Management first reported a position in Disc Medicine in Q2 2024 and has held it in 6 quarters since.
  • Silverarc Capital Management's Disc Medicine position peaked at $12.5M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.